Patient controlled analgesia by proxy  by Guess, C. et al.
Greater ease in assigning patients on individual units
As the unit continues with the development of the tool, the
importance of objectivity, statistical validity, documentation, and
the ability to discriminate between patients is emphasized.
462
BLOOD AND MARROW TRANSPLANTATION FOR HIGH-RISK SICKLE
CELL DISEASE: CLINICAL CHALLENGES
Olson, E.A., Cairns, C. AFLAC Cancer Center and Blood Disorder
Service, Emory University School of Medicine, Children’s Healthcare of
Atlanta, Atlanta, GA.
Patients with sickle cell disease (SCD) continue to have increased
morbidity and mortality secondary to clinical complications. HLA
matched sibling allogeneic bone marrow transplant (BMT) has
been investigated in young patients with high risk SCD patients.
Patients with high-risk SCD patients commonly have had a cere-
bral vascular accident (CVA), acute chest syndrome (ACS), or
recurrent painful crisis (VOC). Our institution has performed 20
allogeneic BMT in children with high risk SCD. Patients with
SCD have additional challenges beyond the standard BMT sup-
portive care. Astute nursing assessment, management, and patient-
family education speciﬁcally related to SCD BMT is crucial to a
successful outcome. Education includes the treatments, side ef-
fects, and BMT routines. SCD patients are at increased risk for
cerebral vascular accidents due to thrombocytopenia and hyper-
tension. High-risk SCD patients have often received chronic trans-
fusion therapy before BMT; many have developed antibodies to
red blood cells and platelets. Careful screening of donor units is
essential. It is suggested that hemoglobin be maintained 	10 and
platelets 	50,000, so proactive planning is required to assure an
adequate supply of blood products. In SCD, a determined attempt
to prevent GVHD is warranted. Cyclosporine (CSA) is adminis-
tered as GVHD prophylaxis, close monitoring of CSA pharmaco-
kinetics is essential. CSA, especially at higher serum levels, often
causes hypertension and decreased serum magnesium, which can
lead to seizures if not treated promptly. Strict blood pressure
parameters need to be observed and serum magnesium must be
monitored closely. Compliance is essential during BMT; non-
compliance has been shown to lead to GVHD, hypertension, and
seizures. Families are counseled on the importance of compliance
prior to BMT with reinforcement throughout the BMT process.
Patients and families are given written, daily, medication schedules
that require charting and review prior to discharge to help enhance
compliance. BMT has been successful in high-risk SCD patients.
However, vigilance must be maintained to avoid complications of
BMT, which may be far worse than sickle cell disease itself.
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IMPLEMENTATION OF DISCHARGE VIDEOS FOR PEDIATRIC PATIENTS
UNDERGOING BLOOD AND MARROW TRANSPLANTATION: BRIDGING
THE GAP BETWEEN INPATIENT AND OUTPATIENT CARE
Kokoszka, A., Talbert, G., Yarwood, K., Garmhausen, L., Kurtzberg, J.
Pediatric Blood and Marrow Transplant Program, Duke University
Medical Center, Durham, NC.
The transition between inpatient and outpatient care for children
post blood and marrow transplantation is a stressful time for their
primary caregivers. Caregivers are required to provide complex
care including intravenous infusions, intravenous medication ad-
ministration, and physical care of central lines and other devices.
Education of the caregiver requires a coordinated effort between
the home care/home infusion company, the outpatient clinic, and
the inpatient team. Ideally, teaching should begin weeks prior to
discharge. The purpose of this abstract is to describe the Duke
Pediatric Blood and Marrow Transplant Program’s Discharge
Teaching initiative. In conjunction with classes and one-on-one
teaching by the home health discharge nurse, the key component
of this program is an instructional DVD that provides detailed
education on the key components of care that will be required after
discharge. These include central line dressing changes, cap
changes, and blood draws. The caregiver is required to view the
instructional DVD prior to being discharged from the hospital.
The inpatient care nurse is responsible for providing additional
education based on each caregiver’s needs. Caregivers are then
required to successfully demonstrate that they are able to perform
these tasks prior to discharge.
The instructional DVD is the catalyst for the second phase of
education which includes intravenous pumps and medications. The
nurse discharge planner also begins that phase of teaching while
the child is inpatient. The implementation of this video has greatly
improved patient and staff satisfaction. Caregivers are able to
watch the video and practice the skills on their own time. Staff
articulated that their teaching time was more efﬁcient and that
caregivers were better prepared for the discharge process. The
discharge planner was able to spend more time on the more
complex issues such as intravenous infusions. Overall, this video
has made teaching time more efﬁcient and has improved parents’
satisfaction in the discharge planning process.
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COMPASSION FATIGUE: CARE FOR THE CARING
Blackstock, J., Frey, M., Kurtzberg, J. Duke University Hospital,
Durham, NC.
Compassion fatigue is the emotional and physical response,
which can develop in individuals exposed, through their work or
other types of support, to people who are suffering. It is commonly
seen in health care professionals working with individuals suffering
from the consequences of a serious illness, traumatic event, or
death, particularly of a child. Professionals who work with people
who are suffering must contend with not only the normal stress or
dissatisfaction of work, but also with the emotional and personal
feelings for suffering (Gentry, 2001). One group that is often
overlooked in the aftermath of a traumatic event is the healthcare
professional. Compassion fatigue can result in a preoccupation or
tension with the individual or event. Healthcare professionals often
report feelings of burn-out and frustration. Staff will experience
physical and emotional manifestations of this syndrome. Many will
leave the ﬁeld because of compassion fatigue. The purpose of this
poster is to describe compassion fatigue and the impact it has on
the healthcare professional (speciﬁcally nurses). The signs and
symptoms of the syndrome will be described. An additional goal of
this poster will be to deﬁne strategies and copings skills for the
management of compassion fatigue. Finally, the Duke Pediatric
Blood and Marrow Transplant compassion fatigue model will be
described. This program was developed in 2004 in an attempt to
reduce burnout and turnover among nursing staff.
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PATIENT CONTROLLED ANALGESIA BY PROXY
Guess, C., Frey, M.A., Martin, P.L., Kurtzberg, J. Pediatric Blood and
Marrow Transplant Program at Duke University Medical Center,
Durham, NC.
Patient controlled analgesia (PCA) is an effective and efﬁcient
method of controlling pain. When used as prescribed and in-
tended, the risk of over sedation is low (JCAHO 2004). Pediatric
BMT patients experience pain from mucositis, skin GvHD, VOD,
and other complications. Effective pain management in a pediatric
BMT unit is often complicated by the fact that many young
patients are unable to either physically push the PCA button or
developmentally understand the association of pain relief with
pushing the button. In many BMT units, including our own, the
parent administers PCA “by proxy”. Recently JCAHO and other
patient safety organizations have focused on PCA by proxy. Serious
adverse events have been reported when family members, caregiv-
ers, and others administer the analgesic for the patient. The Joint
Commission’s Sentinel Event database contains only one medica-
tion error related to PCA by proxy. The U.S Pharmacopeia (USP)
medication database reported ﬁfteen cases of error with PCA by
proxy. Twelve were from family/parent controlled PCA, 2 were
RN administered, and 1 was by pharmacy (JCAHO 2004). One
death involving a nurse administered PCA has been reported in-
volving a post-op elderly patient with multiple medical issues. The
purpose of this abstract is to describe the Duke Pediatric Blood and
Transplant Nursing
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Marrow Transplant pediatric PCA by proxy protocol. This proto-
col represents a collaborative reevaluation and multidisciplinary
team effort. The two major priorities of this group were to main-
tain patient safety and ensure adequate pain management. The
results of this effort will be shared. The key components of the plan
include appropriate patient selection, parental education on PCA
by proxy, parental pain assessment and documentation, and eval-
uation of the safety and effectiveness of the intervention. This
presentation is based on our experience from July 1996 to Septem-
ber 2005 and includes 869 transplants in pediatric patients (median
age of 6.1 years) of whom 373 patients were under the age of 4
years. The vast majority of these patients beneﬁted from PCA by
proxy. There were no reported serious adverse events in these
patients.
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TIMELINE OF RISKS FOR INFECTIONS FOLLOWING Allo BMT: A CUT-
TING EDGE TOOL DESIGNED FOR NURSES
Austria-Granada, M.R. The University of Texas MD Anderson Cancer
Center, Houston, TX.
Infectious complications continue to pose enormous challenges
to the health care professionals experienced in treating the immu-
nocompromised population. After Allogeneic Bone Marrow
Transplantation (BMT), the presence of graft versus host disease
impairs the immune system, thereby delaying the host defenses’
ability to ﬁght invasive microorganisms. According to researchers,
life-threatening infections occur approximately in 30 % of alloge-
neic BMT patients, resulting in an increasing cause for concern
among clinicians. Nurses, as advocates and educators, are faced
with many questions from patients and their caregivers regarding
the risks and the steps to avoid exposure and occurrence of any
illness. As members of the health care team, they have a signiﬁcant
role in the assessment, evaluation, and management of allogeneic
BMT patients who are most vulnerable to pathogens. Their strong
knowledge base of the infectious process is integral in providing
immediate interventions, therefore, preventing secondary conse-
quences and unnecessary treatments that will affect the patients’
overall survival. A tool was developed to assist nurses to recognize
the common infections and drug therapies used in the 3 crucial
stages of the transplant process, namely: pre-engraftment (0-30
days post BMT), post-engraftment (30-100 days post BMT), and
late post engraftment (100 days post BMT). It is utilized as a
communication plan ensuring that BMT patients receive appro-
priate monitoring during their entire course of treatment. It also
serves as a framework of reference not only for BMT nurses, but
ﬂoat nurses and students as well. Most importantly, this instrument
beneﬁts nurses to better comprehend and carry out their essential
roles utilizing the knowledge and the skills they possess to effec-
tively and safely deliver the highest quality of nursing care.
A tool citing the common infections, treatments and nursing
responsibilities in the three time periods after Allogeneic BMT will
be presented.
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EMPOWERING MOBILITY IN ALLOGENEIC PATIENTS: AN ESSENTIAL
KEY TO COMBAT STEROID MYOPATHY
Estrella, J.M.E. The University of Texas M. D. Anderson Cancer
Center, Houston, TX.
Nurses play an important role in the recovery of allogeneic
transplant patients. A holistic approach enables nurses to address
the needs of patients who are faced with issues arising from recov-
ery of counts, prevention of infection, and their biggest challenge
yet, minimizing the complications of graft-versus-host disease
(GVHD). Studies reveal that 50% have a risk developing acute or
chronic GVHD despite use of anti-rejection drugs. Steroid therapy
is the frontline treatment for GVHD and is tapered depending on
response to the treatment and improvement of symptoms. Steroid
myopathy is essentially ubiquitous among patients with GVHD
and the most effective way to treat it is to eliminate or decrease the
dose of steroids. Unfortunately, when GVHD ﬂares up and ste-
roids are resumed, steroid myopathy recurs and the vicious cycle
goes on. Constant mobility during the entire transplant process
lessens the incidence of steroid myopathy. It is essential that a
physical/occupational therapy (PT/OT) consult be obtained once
high doses of steroids are initiated. Rehabilitation starts upon
admission, thus, the future goal for BMT is to incorporate Physical
Medicine and Rehabilitation into the patient’s plan of care. The
BMT nurse’s goal is to empower and encourage patients to remain
mobile and maintain activities of daily living. At our comprehen-
sive cancer center, ambulation around the unit is promoted at least
3 times a day—a mile each time or as tolerated. Gait is the physical
activity most known and better adapted to improve physical status.
Moreover, range of motion, resistive or endurance exercises are
also utilized in accordance to the PT/OT regimen. Upon dis-
charge, patients are also encouraged to participate in out-patient
rehabilitation programs. A case study will be presented, including
a chart that describes the nursing interventions and various devices
used at our institution reﬂecting the rehabilitation care provided to
patients with steroid myopathy.
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ADMINISTRATION OF IV IMMUNOSUPPRESSIVE AGENTS AND THE
DRAWING OF THEIR LEVELS: A HOW TO GUIDE FOR NURSES
Lahr, S.L. Froedtert Hospital, Milwaukee, WI.
Topic: To show the importance of dedicating a line to admin-
ister immunosuppressive drugs (ISD) to ensure proper dosing for
the BMT patient. Purpose/Background/Rationale: Early in
2005, Froedtert Hospital (FH) experienced several patients who
had continuously high ISD levels without showing signs of toxicity
or decreasing lab values after dose reduction. At this point, it was
decided the nurses needed to draw both a peripheral level and level
from the central venous catheter (CVL) in order to see if the 2
levels correlated. Up until this point, it had been our policy to draw
all levels from the CVL only. In all of the patients where dual labs
were drawn, the CVL level was signiﬁcantly higher than the level
drawn peripherally. This discrepancy has many negative conse-
quences including poor immunosuppression for the BMT patient,
possible increase in the rate of GVHD, unnecessary changes in
drug dosages and inaccurate lab data. This poster will describe the
nursing interventions taken to correct this problem showing that
dedicating a line is an important part of insuring accurate lab and
dosing levels when it is not possible to draw a peripheral level.
Intervention: Nurse interviews and audits showed signiﬁcant vari-
ance in the knowledge of the ISD policy. Once initial data was
collected policy changes included the drawing of peripheral levels
only with continued line dedication. Staff was reeducated on
proper procedure and documentation. Procedure reminders were
placed in areas of patient care. Evaluation: Dual labs are again
being drawn to see if post education data shows an increased
correlation between peripheral and CVL values. Preliminary re-
sults show that there has been a signiﬁcant improvement. Discus-
sion: This presentation will demonstrate that continuity in nursing
practice will insure the proper dosing of the BMT patient unable
to receive a peripheral blood draw.
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PREVENTION AND TREATMENT OF MUCOSITIS: DEVELOPMENT OF
PATIENT SPECIFIC ORAL CARE
Mims, C.E., Parker, E.E. UAB Hospital, Birmingham, AL.
Oral mucositis is a condition that ranges in severity from redness
to severe ulceration. It is a severe and painful complication that
occurs in patients receiving high dose chemotherapy prior to bone
marrow or stem cell transplantation. Mucositis remains one of the
most under treated problems in patients with cancer. It has been
rated as the most debilitating side effect by patients with cancer
undergoing bone marrow transplantation. Oral care is necessary
prior to chemotherapy as well as throughout the course of therapy
for any patient with cancer at risk for developing mucositis. Al-
though there are many pharmacologic interventions available,
there is not a universally accepted strategy used to reduce the
incidence of mucositis or treat active mucositis. This can make it
challenging for clinicians to choose the most effective mouth care
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